Core Points - A class action lawsuit has been filed against CoreWeave, Inc. and certain senior executives for securities fraud following significant stock drops due to potential violations of federal securities laws [1][3] - Investors are encouraged to seek additional information regarding the lawsuit and their legal options [2][9] Company Overview - CoreWeave is an AI-focused cloud computing company that operates data centers providing high-performance GPU infrastructure [4] - The company relies on partnerships, including a merger agreement with Core Scientific announced on July 7, 2025 [4] Allegations and Stock Performance - CoreWeave allegedly overstated its ability to meet customer demand and concealed significant construction delays at its data centers [5] - The stock price dropped significantly after key announcements: - On October 30, 2025, the stock fell by $8.87 (over 6%) from $139.93 to $131.06 after the merger with Core Scientific was terminated [6] - On November 10, 2025, the stock dropped by $17.22 (over 16%) from $105.61 to $88.39 following lowered guidance due to construction delays [7] - On December 15, 2025, the stock decreased by $2.85 (over 3%) from $72.35 to $69.50 after reports of further delays in a major data center project [8]

Core Viewpoint - A class action lawsuit has been filed against BellRing Brands, Inc. and certain senior executives for securities fraud, following a significant drop in stock price attributed to potential violations of federal securities laws [1][3]. Company Overview - BellRing Brands develops, markets, and sells "convenient nutrition" products, primarily known for its ready-to-drink protein shakes under the Premier Protein brand [4]. Allegations of Securities Fraud - The lawsuit claims that BellRing misrepresented sales growth as being driven by increased consumer demand, attributing it to "organic growth" and "strong macro tailwinds," while downplaying competitive pressures [4]. - It is alleged that the actual sales were inflated due to key customers stockpiling inventory, rather than reflecting genuine demand or brand momentum [4]. Stock Price Impact - On May 6, 2025, BellRing's stock dropped by $14.88 per share (19%), from $78.43 to $63.55, after the CFO indicated that several key retailers had reduced their inventory levels, leading to a forecast of low single-digit sales growth for Q3 [5]. - Following the release of Q3 2025 financial results on August 4, 2025, and subsequent comments from the CEO regarding increased competition, the stock fell by $17.46 per share (nearly 33%), from $53.64 to $36.18 [6][7]. Legal Proceedings - Investors have until March 23, 2026, to request to lead the case in the U.S. District Court for the Southern District of New York, under the caption Denha v. BellRing Brands, Inc. [3].

New York, New York--(Newsfile Corp. - February 20, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Plug Power Inc. (NASDAQ: PLUG) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Plug Power, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/plug-power ...

New York, New York--(Newsfile Corp. - February 20, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-hea ...

Core Viewpoint - A class action lawsuit has been filed against Kyndryl Holdings, Inc. and certain senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Kyndryl is a leading provider of enterprise technology services, offering advisory, implementation, and managed service capabilities to customers in over 60 countries. It is recognized as the world's largest IT infrastructure services provider [4]. Allegations - The lawsuit alleges that Kyndryl misrepresented its cash management practices, including the drivers of its adjusted free cash flow metric, and the effectiveness of its internal controls over financial reporting for FY2025 and the first three quarters of FY2026 [5]. Stock Performance - On February 9, 2026, Kyndryl announced a delay in releasing its fiscal Q3 2026 financial statement due to an accounting review of its cash management practices, which led to the immediate departures of its CFO and General Counsel. This announcement resulted in a stock price drop of $12.90 per share, or 55%, from $23.49 on February 8, 2026, to $10.59 on February 9, 2026 [6][7].

Core Viewpoint - Hub Group Inc. is under investigation for potential violations of federal securities laws, specifically regarding misrepresentation of transportation costs and accounts payable for the first nine months of 2025 [2][3]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is leading the investigation into Hub Group for possible misrepresentation of its financial data [1][2]. - The investigation focuses on whether Hub Group inaccurately reported its purchased transportation costs and accounts payable [2]. Group 2: Stock Performance - Hub Group announced a delay in releasing its fourth quarter and full year 2025 financial results, which led to a significant drop in its stock price [3]. - On February 6, 2026, Hub Group's stock price fell over 24% during trading following the announcement of the delay and the need to restate financial statements due to an error in reporting [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims for Grail, Inc. investors regarding losses that may be recoverable under federal securities laws following the company's failure to meet clinical trial endpoints [1][1]. Group 1: Investigation Details - The investigation focuses on Grail's executive officers and their compliance with federal securities laws [1]. - Grail disclosed on February 19, 2026, that its NHS-Galleri trial did not achieve its primary clinical endpoint, leading to a significant decline of approximately 48% in share price during after-hours trading [1][1]. Group 2: Investor Information - Investors who purchased Grail securities and suffered losses are encouraged to join the investigation without any cost or obligation [1]. - Contact information for inquiries includes Jim Baker at (619) 814-4471 or via email [1]. Group 3: Johnson Fistel Overview - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights and securities class action lawsuits, with a history of recovering approximately $90.725 million for clients [1][1]. - The firm has been ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services in 2024, marking its eighth recognition as a top plaintiffs' securities law firm in the U.S. [1].

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in significant stock price declines [3][4]. Company Overview - Richtech Robotics develops, manufactures, deploys, and sells robotic solutions for automation in the service industry [2]. Legal Allegations - The class action lawsuit claims that Richtech Robotics falsely asserted a collaborative and commercial relationship with Microsoft during the class period [3]. - An article published by Hunterbrook Media on January 29, 2026, stated that Microsoft denied any partnership with Richtech Robotics, leading to a more than 29% drop in Richtech Robotics Class B stock over two trading days [4]. Class Action Process - Investors who purchased Richtech Robotics securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to represent the interests of all class members [5]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [6].

Core Viewpoint - A class action lawsuit has been filed against Ostin Technology Group Co., Ltd. for alleged securities fraud, resulting in significant investor losses exceeding $950 million in market capitalization [1]. Group 1: Lawsuit Details - The class action lawsuit concerns whether Ostin and certain officers and/or directors engaged in unlawful business practices [1]. - Investors have until April 17, 2026, to request to be appointed as Lead Plaintiff if they purchased Ostin securities during the Class Period [1]. Group 2: Allegations and Financial Impact - The complaint alleges that from around December 2024, Ostin and its co-conspirators engaged in a securities fraud scheme that inflated the company's market capitalization from approximately $22 million to over $1 billion [1]. - On June 26, 2025, Ostin investors faced substantial losses as the stock price fell from an intraday high of $9.40 to a closing price of $0.55, resulting in a loss of over 94% of the company's market capitalization in a single day [1].

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KDDI Corporation - KDDIY [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of KDDI Corporation ("KDDI" or the "Company") (OTCMKTS: KDDIY). Such investors are advised to contact Danielle Peyton at [[email protected]] or 646-581-9980, ext. 7980.The investigation concerns whether KDDI and certain of its officers and/or directors have engage ...